Page 112 - Read Online

Page 20 of 20 Rhoades et al. J Transl Genet Genom 2019;3:1. I https://doi.org/10.20517/jtgg.2018.26

schizophrenia: detection of putative mutations involving regulatory enhancer elements. World J Biol Psychiatry 2017;20:1-11.
111. Ruderfer DM, Fanous AH, Ripke S, McQuillin A, Amdur RL, et al. Polygenic dissection of diagnosis and clinical dimensions of bipolar
disorder and schizophrenia. Mol Psychiatry 2014;19:1017-24.
112. Bigdeli TB, Bacanu SA, Webb BT, Walsh D, O’Neill FA, et al. Molecular validation of the schizophrenia spectrum. Schizophr Bull
2014;40:60-5.
113. Meyer U, Schwarz MJ, Müller N. Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of
negative/cognitive symptoms and beyond. Pharmacol Ther 2011;132:96-110.
114. Cheung C, Yu K, Fung G, Leung M, Wong C, et al. Autistic disorders and schizophrenia: related or remote? An anatomical likelihood
estimation. PLoS One 2010;5:e12233.
115. Rowland LM, Pradhan S, Korenic S, Wijtenburg SA, Hong LE, et al. Elevated brain lactate in schizophrenia: a 7 T magnetic resonance
spectroscopy study. Transl Psychiatry 2016;6:e967.
116. Fryer SL, Roach BJ, Ford JM, Turner JA, van Erp TG, et al. Relating intrinsic low-frequency BOLD cortical oscillations to cognition in
schizophrenia. Neuropsychopharmacology 2015;40:2705-14.
117. Takata A, Ionita-Laza I, Gogos JA, Xu B, Karayiorgou M. De novo synonymous mutations in regulatory elements contribute to the genetic
etiology of autism and schizophrenia. Neuron 2016;89:940-7.
118. Kirov G. CNVs in neuropsychiatric disorders. Hum Mol Genet 2015;24:R45-9.
119. Xing J, Kimura H, Wang C, Ishizuka K, Kushima I, et al. Resequencing and association analysis of six PSD-95-related genes as possible
susceptibility genes for schizophrenia and autism spectrum disorders. Sci Rep 2016;6:27491.
120. Kasem E, Kurihara T, Tabuchi K. Neurexins and neuropsychiatric disorders. Neurosci Res 2018;127:53-60.
121. Khanzada NS, Butler MG, Manzardo AM. GeneAnalytics pathway analysis and genetic overlap among autism spectrum disorder, bipolar
disorder and schizophrenia. Int J Mol Sci 2017; doi: 10.3390/ijms18030527.
122. Schmidt RJ, Tancredi DJ, Ozonoff S, Hansen RL, Hartiala J, et al. Maternal periconceptional folic acid intake and risk of autism spectrum
disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study. Am J
Clin Nutr 2012;96:80-9.
123. Malkova NV, Yu CZ, Hsiao EY, Moore MJ, Patterson PH. Maternal immune activation yields offspring displaying mouse versions of the
three core symptoms of autism. Brain Behav Immun 2012;26:607-16.
124. Morris JA. Schizophrenia, bacterial toxins and the genetics of redundancy. Med hypotheses 1996;46:362-6.
125. Meyer U, Schwendener S, Feldon J, Yee BK. Prenatal and postnatal maternal contributions in the infection model of schizophrenia. Exp
Brain Res 2006;173:243-57.
126. van der Ven E Selten JP. Migrant and ethnic minority status as risk indicators for schizophrenia: new findings. Curr Opin Psychiatry
2018;31:231-6.
127. Egerton A, Howes OD, Houle S, McKenzie K, Valmaggia LR, et al. Elevated striatal dopamine function in immigrants and their children: a
risk mechanism for psychosis. Schizophr Bull 2017;43:293-301.
128. Ohi K, Shimada T, Yasuyama T, Uehara T, Kawasaki Y. Variability of 128 schizophrenia-associated gene variants across distinct ethnic
populations. Transl Psychiatry 2017; doi: 10.1038/tp.2016.260.
129. Eack SM, Bahorik AL, Newhill CE, Neighbors HW, Davis LE. Interviewer-perceived honesty as a mediator of racial disparities in the
diagnosis of schizophrenia. Psychiatr Serv 2012;63:875-80.
130. Pinto R, Ashworth M, Jones R. Schizophrenia in black caribbeans living in the UK: an exploration of underlying causes of the high
incidence rate. Br J Gen Pract 2008;58:429-34.
131. Hamilton JE, Heads AM, Meyer TD, Desai PV, Okusaga OO, et al. Ethnic differences in the diagnosis of schizophrenia and mood disorders
during admission to an academic safety-net psychiatric hospital. Psychiatry Res 2018;267:160-7.
132. Vassos E, Di Forti M, Coleman J, Iyegbe C, Prata D, et al. An examination of polygenic score risk prediction in individuals with first-episode
psychosis. Biol Psychiatry 2017;81:470-7.
133. Olde Loohuis LM, Mangul S, Ori APS, Jospin G, Koslicki D, et al. Transcriptome analysis in whole blood reveals increased microbial
diversity in schizophrenia. Transl Psychiatry 2018;8:96.
134. Sanders AR, Drigalenko EI, Duan J, Moy W, Freda J, et al. Transcriptome sequencing study implicates immune-related genes differentially
expressed in schizophrenia: new data and a meta-analysis. Transl Psychiatry 2017; doi: 10.1038/tp.2017.47.
135. Chestkov IV1, Jestkova EM2, Ershova ES1, Golimbet VE3, Lezheiko TV, et al. Abundance of ribosomal RNA gene copies in the genomes
of schizophrenia patients. Schizophr Res 2018; doi: 10.1016/j.schres.2018.01.001.
136. Brennand KJ, Simone A, Jou J, Gelboin-Burkhart C, Tran N, et al. Modelling schizophrenia using human induced pluripotent stem cells.
Nature 2011;473:221-5.